184 related articles for article (PubMed ID: 34868930)
1. Impact of Tumor-Stroma Ratio on the Prognosis of Colorectal Cancer: A Systematic Review.
Gao J; Shen Z; Deng Z; Mei L
Front Oncol; 2021; 11():738080. PubMed ID: 34868930
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis.
Wu J; Liang C; Chen M; Su W
Oncotarget; 2016 Oct; 7(42):68954-68965. PubMed ID: 27661111
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Tumor-Stroma Ratio in Rectal Cancer: A Systematic Review and Meta-analysis.
Zhu Y; Jin Z; Qian Y; Shen Y; Wang Z
Front Oncol; 2021; 11():685570. PubMed ID: 34123856
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of low CDX2 expression in colorectal cancers with a high stromal content - a short report.
Sandberg TP; Sweere I; van Pelt GW; Putter H; Vermeulen L; Kuppen PJ; Tollenaar RAEM; Mesker WE
Cell Oncol (Dordr); 2019 Jun; 42(3):397-403. PubMed ID: 30847807
[TBL] [Abstract][Full Text] [Related]
6. Concurrent Comparison of the Prognostic Values of Tumor Budding, Tumor Stroma Ratio, Tumor Infiltrating Pattern and Lymphocyte-to-Monocyte Ratio in Colorectal Cancer Patients.
Zhang Y; Liu Y; Qiu X; Yan B
Technol Cancer Res Treat; 2021; 20():15330338211045826. PubMed ID: 34658263
[No Abstract] [Full Text] [Related]
7. Prognostic Efficacy of Tumor-Stroma Ratio in Women With Breast Cancer: A Meta-Analysis of Cohort Studies.
Jiang P; Chen Y; Liu B
Front Oncol; 2021; 11():731409. PubMed ID: 34976792
[TBL] [Abstract][Full Text] [Related]
8. Tumor-stroma ratio(TSR) as a potential novel predictor of prognosis in digestive system cancers: A meta-analysis.
Zhang R; Song W; Wang K; Zou S
Clin Chim Acta; 2017 Sep; 472():64-68. PubMed ID: 28729135
[TBL] [Abstract][Full Text] [Related]
9. Significance of Tumor-Stroma Ratio (TSR) in Predicting Outcomes of Malignant Tumors.
Pyo JS; Kim NY; Min KW; Kang DW
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512068
[No Abstract] [Full Text] [Related]
10. Is microsatellite instability-high really a favorable prognostic factor for advanced colorectal cancer? A meta-analysis.
Wang B; Li F; Zhou X; Ma Y; Fu W
World J Surg Oncol; 2019 Oct; 17(1):169. PubMed ID: 31639018
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis.
Juo YY; Johnston FM; Zhang DY; Juo HH; Wang H; Pappou EP; Yu T; Easwaran H; Baylin S; van Engeland M; Ahuja N
Ann Oncol; 2014 Dec; 25(12):2314-2327. PubMed ID: 24718889
[TBL] [Abstract][Full Text] [Related]
12. Prognostic stratification of patients with pT4bN0M0 colorectal cancer following multivisceral resection: a multi-institutional case series analysis.
Quan J; Zuo K; Li G; Liu J; Mei S; Hu G; Qiu W; Zhuang M; Meng L; Wang X; Chang H; Tang J
Int J Surg; 2024 May; ():. PubMed ID: 38768462
[TBL] [Abstract][Full Text] [Related]
13. The advanced lung cancer inflammation index is a prognostic factor for gastrointestinal cancer patients undergoing surgery: a systematic review and meta-analysis.
Liu XR; Wang LL; Zhang B; Liu XY; Li ZW; Kang B; Yuan C; Wei ZQ; Peng D
World J Surg Oncol; 2023 Mar; 21(1):81. PubMed ID: 36879283
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of desmoplastic stromal reaction, tumor budding and tumor-stroma ratio in stage II colorectal cancer.
Fan S; Cui X; Zheng L; Ma W; Zheng S; Wang J; Qi L; Ye Z
J Gastrointest Oncol; 2022 Dec; 13(6):2903-2921. PubMed ID: 36636094
[TBL] [Abstract][Full Text] [Related]
15. Rate of dissemination and prognosis in early and advanced stage colorectal cancer based on microsatellite instability status: systematic review and meta-analysis.
Toh JWT; Phan K; Reza F; Chapuis P; Spring KJ
Int J Colorectal Dis; 2021 Aug; 36(8):1573-1596. PubMed ID: 33604737
[TBL] [Abstract][Full Text] [Related]
16. Oral versus intravenous fluoropyrimidines for colorectal cancer.
Chionh F; Lau D; Yeung Y; Price T; Tebbutt N
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD008398. PubMed ID: 28752564
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of NRAS Gene for Survival of Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
Hu Y; Tao SY; Deng JM; Hou ZK; Liang JQ; Huang QG; Li LH; Li HB; Chen YM; Yi H; Chen XL; Liu H
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3001-3008. PubMed ID: 30484984
[TBL] [Abstract][Full Text] [Related]
18. Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer.
Yan D; Ju X; Luo B; Guan F; He H; Yan H; Yuan J
BMC Cancer; 2022 Oct; 22(1):1082. PubMed ID: 36271354
[TBL] [Abstract][Full Text] [Related]
19. Tumor-stroma ratio (TSR) in non-small cell lung cancer (NSCLC) patients after lung resection is a prognostic factor for survival.
Xi KX; Wen YS; Zhu CM; Yu XY; Qin RQ; Zhang XW; Lin YB; Rong TH; Wang WD; Chen YQ; Zhang LJ
J Thorac Dis; 2017 Oct; 9(10):4017-4026. PubMed ID: 29268412
[TBL] [Abstract][Full Text] [Related]
20. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
